Log in
Enquire now
Circle Pharma

Circle Pharma

Biotechnology company developing cell permeable macrocyclic peptide therapeutics using an automated chemistry synthesis.

OverviewStructured DataIssuesContributors
Is a
Organization
Organization
Company
Company
B2X
B2B
B2B
Board of Directors
‌
Thilo Schroeder
‌
James Evangelista
‌
Matthew P. Jacobson
David J. Earp
David J. Earp
‌
John Josey
‌
Walter H. Moos
CEO
David J. Earp
David J. Earp
Company Operating Status
Active
Country
United States
United States
Crunchbase URL
crunchbase.com/organiz...e-pharma
Email Address
info@circlepharma.com
Facebook URL
@CirclePharma
Founded Date
2012
0
Founder
‌
Matthew P. Jacobson
Glassdoor ID
1738518
Industry
Pharmaceutical industry
Pharmaceutical industry
Technology
Technology
Biotechnology
Biotechnology
Healthcare
Healthcare
Investors
‌
Pandect Bioventures
The Column Group
The Column Group
Mission Bay Capital
Mission Bay Capital
Jude Gomila
Jude Gomila
Nextech Invest
Nextech Invest
‌
Euclidean Capital
Eli Lilly
Eli Lilly
Latest Funding Round Date
September 3, 2024
Latest Funding Round Amount (USD)
90,000,000
Latest Funding Type
Series D
Series D
LinkedIn URL
@company/6588337
Location
South San Francisco, California
South San Francisco, California
San Francisco
San Francisco
United States
United States
Number of Employees (Ranges)
11 – 50
0
Patents Assigned (Count)
1
Total Funding Amount (USD)
205,500,000
Twitter URL
@CirclePharma
Official Website
circlepharma.com

Find more companies like Circle Pharma

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.